4/4/2014 1:00:00 AM
KineMed, Inc. announced today that Dr. Marc Hellerstein, KineMed’s President and CSO, will give an invited presentation titled “Quantifying in vivo metabolic pathway fluxes and network dynamics using heavy water and mass spectrometry: A new class of disease biomarkers” at the American Association for Cancer Research Annual Meeting, taking place April 5-9, in San Diego, California.
3/20/2014 1:00:00 AM
KineMed, Inc. announced today that abstracts were accepted for three oral and four poster presentations highlighting its work in liver fibrosis at the Keystone Fibrosis Symposium taking place March 23–28, 2014 in Keystone, Colorado. Dr. Scott Turner, KineMed’s Executive Vice President of Research, Dr. Claire Emson, KineMed’s Director of Fibrosis Research, and Dr. Martin Decaris, postdoctoral researcher in Cellular and Molecular Kinetics at KineMed, will represent KineMed at the conference.
3/19/2014 1:00:00 AM
KineMed, Inc. announced today that Dr. Patrizia Fanara, Vice President of Neuroscience at KineMed, will give the presentation titled “Tracking Brain Function and Dysfunction Using Translational Kinetic BioMarkers”. Dr. Fanara’s presentation is today, from 11:05-11:30 AM PDT, at the Hyatt Regency Mission Bay San Diego, California as part of the 3rd Neurological Biomarkers Conference.
Marc Hellerstein, M.D., Ph.D., President and Chief Scientific Officer
talks about the power of Proteome Dynamics at the Personalized Medicine World Conference